Director/PDMR Shareholding
17 10월 2007 - 4:01PM
UK Regulatory
RNS Number:8368F
Phoqus Pharmaceuticals PLC
17 October 2007
Phoqus Pharmaceuticals plc
Directors' share dealings
West Malling, UK, 17 October 2007: Phoqus Pharmaceuticals plc (AIM: PQS)
("Phoqus" or the "Company"), the drug development company, announces dealings in
Company shares by Directors.
Anthony Playle, Non-Executive Director of the Company, exercised options over
40,843 ordinary shares ("Shares") in Phoqus (representing 0.09 per cent of the
issued share capital of the Company) at an exercise price of 0.01 pence per
ordinary share on 16 October 2007. These share options were originally granted
by the Company on 3 November 2005. Following the exercise of these share
options, Mr Playle has a total holding in the Company amounting to 40,947 Shares
(representing 0.09 per cent of the issued share capital of the Company).
As previously announced, share options granted by the Company on 3 November 2005
were to be satisfied by the transfer of Shares held by certain institutional
shareholders. In order to facilitate the transfer of Shares to option-holders,
some of the institutional shareholders transferred shares to Dr Peter Johnson,
Chief Financial Officer, to hold the Shares as their nominee pending exercise of
the share options by the option-holders, after which he would transfer the
relevant Shares to the exercising option-holders.
Accordingly, following the exercise of the above share options by Mr Playle,
together with share options exercised by other option-holders, Dr Johnson
transferred 101,779 Shares to the exercising shareholders in the usual way on 16
October 2007 in his capacity as nominee shareholder.
Following the above transfer of 101,779 Shares to exercising option-holders on
16 October, 177,740 Shares are now held by Dr Johnson in his capacity as
nominee, representing 0.39 per cent of the issued share capital of the Company.
Dr Johnson's beneficial ownership of Phoqus shares remains unchanged at 294,926
ordinary shares, or 0.64 per cent of the issued share capital of the Company.
Enquiries:
Phoqus Pharmaceuticals plc
Suzanne Smith, Company Secretary Tel: 01732 870227
Nomura Code Securities Limited
Phil Walker Tel: 020 7776 1200
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEAEEXFENXFEE
Phoqus (LSE:PQS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Phoqus (LSE:PQS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Phoqus (London Stock Exchange)의 실시간 뉴스: 최근 기사 0
More Phoqus Pharma News Articles